
-
Defending champion I Am Maximus heads final field for Grand National
-
Rubio says US committed to NATO - but tells allies to spend more
-
India eyes opportunity despite Trump tariffs hit
-
UK show reveals tawdry tale of Shakespeare folio theft
-
Top Russian official in Washington for talks on improving ties
-
Sinner's former physio to blame for failed dope tests, says ex-physical trainer
-
Germany slams Trump tariffs, US tech titans in crosshairs
-
Hungary announces ICC withdrawal as Israel's Netanyahu visits
-
Trump's tariffs sting Asian giants, including US allies
-
India says 'examining the implications' of US tariffs
-
Evenepoel set to make injury return at Tour de Romandie
-
USA sole bidder for 2031 Women's World Cup, UK set to host in 2035 - Infantino
-
McLaren's Norris says it's 'our turn' for success
-
Lessons and liquids: buried alive in Myanmar's earthquake
-
Trump tariffs spark fears for Asian jobs, exporting sectors
-
Runners fly to North Korea for first post-Covid Pyongyang Marathon
-
Hamilton rubbishes claims he's lost faith in Ferrari
-
Nintendo Switch 2 sparks excitement despite high price
-
Sri Lanka's crackdown on dogs for India PM's visit sparks protest
-
S Korea police raise security levels ahead of impeachment verdict
-
Tsunoda vows to bring 'something different' after Red Bull promotion
-
Verstappen not happy with Tsunoda-Lawson Red Bull swap
-
Experts accuse 54 top Nicaragua officials of grave abuses
-
Remains of 30th victim of Los Angeles fires found
-
EU to target US online services after Trump tariffs: France
-
How Trump's 'liberation day' tariffs will impact China
-
Search for long-missing flight MH370 suspended: Malaysia minister
-
Europe hits out at Trump tariffs, keeps door open for talks
-
Lawson vows to prove he belongs in F1 after shock of Red Bull axing
-
Australia sweats through hottest 12 months on record: official data
-
Livestock theft is central to jihadist economy in west Africa
-
South African artist champions hyenas in 'eco-queer' quest
-
Danish PM in 'unity' Greenland visit amid US takeover threats
-
Taiwan says US tariffs 'highly unreasonable'
-
Lawson says ruthless Red Bull axing was 'tough to hear'
-
Trump escalates trade war with sweeping global tariffs
-
Japan says US tariffs 'extremely regrettable', may break WTO rules
-
South Koreans anxious, angry as court to rule on impeached president
-
Juve at in-form Roma with Champions League in the balance
-
Injuries put undermanned Bayern's title bid to the test
-
Ovechkin scores 892nd goal -- three away from Gretzky's NHL record
-
Australian former rugby star Petaia signs for NFL's Chargers
-
China says opposes new US tariffs, vows 'countermeasures'
-
Athletics world watching as 'Grand Slam Track' prepares for launch
-
Heat humble Celtics for sixth straight win, Cavs top Knicks
-
Quake-hit Myanmar's junta chief to head to Bangkok summit
-
New Spielberg, Nolan films teased at CinemaCon
-
Shaken NATO allies to meet Trump's top diplomat
-
Israel's Netanyahu arrives in Hungary, defying ICC warrant
-
Shiny and deadly, unexploded munitions a threat to Gaza children

New US study helps de-mystify Covid brain fog
A small new study published Tuesday by scientists at the US National Institutes of Health suggests that the immune response triggered by coronavirus infections damages the brain's blood vessels and could be responsible for long Covid symptoms.
The paper, published in the journal Brain, was based on brain autopsies from nine people who died suddenly after contracting the virus.
Rather than detecting evidence of Covid in the brain, the team found it was the people's own antibodies that attacked the cells lining the brain's blood vessels, causing inflammation and damage.
This discovery could explain why some people have lingering effects from infection including headache, fatigue, loss of taste and smell, and inability to sleep as well as "brain fog" -- and may also help devise new treatments for long Covid.
NIH scientist Avindra Nath, the paper's senior author, said in a statement: "Patients often develop neurological complications with COVID-19, but the underlying pathophysiological process is not well understood."
"We had previously shown blood vessel damage and inflammation in patients' brains at autopsy, but we didn't understand the cause of the damage. I think in this paper we've gained important insight into the cascade of events."
The nine individuals, aged 24 to 73, were selected from the team's prior study because they showed evidence of blood vessel damage in their brains based on scans.
Their brains were compared to those from 10 controls, with the team examining neuroinflammation and immune responses using a technique called immunohistochemistry.
The scientists discovered that antibodies produced against Covid-19 mistakenly targeted cells that form the "blood-brain barrier" -- a structure designed to keep harmful invaders out of the brain while allowing necessary substances to pass.
Damage to these cells can cause leakage of proteins, bleeding and clots, which elevates the risk of stroke.
The leaks also trigger immune cells called macrophages to rush to the site to repair damage, causing inflammation.
The team found that normal cellular processes in the areas targeted by the attack were severely disrupted, which had implications for things such as their ability to de-toxify and to regulate metabolism.
The findings offer clues about the biology at play in patients with long-term neurological symptoms, and can inform new treatments -- for example, a drug that targets the build-up of antibodies on the blood-brain barrier.
"It is quite possible that this same immune response persists in Long COVID patients resulting in neuronal injury," said Nath.
This would mean that a drug that dials down that immune response could help those patients, he added. "So these findings have very important therapeutic implications."
L.Henrique--PC